Essential Thrombocythemia
📧 Sign up to get email alerts when something new happens for Essential Thrombocythemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2024-12-19Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Ropeginterferon Alfa-2b in Essential Thrombocythaemia Patients [Phase 3]
Phase 3 trial evaluating the efficacy and safety of ropeginterferon alfa-2b in essential thrombocythemia; the study is currently active but …
-
CLINICAL_TRIALS research · 2024-12-16Clinical Trial Update: Efficacy and Safety of Peginterferon in ET and PV. [NA]
This document reports a currently recruiting clinical trial evaluating the efficacy and safety of peginterferon in essential thrombocythemia…
-
CLINICAL_TRIALS research · 2024-12-05Clinical Trial Update: Ruxolitinib in Primary Myelofibrosis and Secondary to Essential Thrombocythemia or Polycythemia Vera
A recruiting clinical trial is evaluating ruxolitinib in patients with myelofibrosis, including primary myelofibrosis and myelofibrosis seco…
-
CLINICAL_TRIALS research · 2024-11-08Clinical Trial Update: Extension Study of P1101 After Completion of Phase 2 Study in PV Patients or Phase 3 Study in ET Patients [Phase 3]
An extension study of P1101 is planned after completion of Phase 2 in polycythemia vera or Phase 3 in essential thrombocythemia; the trial i…
-
CLINICAL_TRIALS research · 2024-11-01Clinical Trial Update: Aquagenic Pruritus in Myeloproliferative Neoplasms
A completed clinical trial investigating aquagenic pruritus in patients with myeloproliferative neoplasms.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-08-27Clinical Trial Update: Myeloproliferative Neoplasms (MPNs) Patient Registry
An update on the Myeloproliferative Neoplasms (MPNs) Patient Registry sponsored by University Health Network in Toronto, currently recruitin…
-
CLINICAL_TRIALS research · 2024-08-12Clinical Trial Update: Myeloproliferative Neoplastic Diseases Observatory From Brest
A Brest-based clinical trial observatory update for myeloproliferative neoplasms, enrolling patients with polycythemia vera, essential throm…
-
CLINICAL_TRIALS research · 2024-07-03Clinical Trial Update: Pegylated Interferon Alfa-2b Versus Interferon Alfa Therapy in Adult Essential Thrombocythemia [Phase 2]
This is a Phase 2 clinical trial comparing pegylated interferon alfa-2b to interferon alfa in adults with essential thrombocythemia; the stu…
-
CLINICAL_TRIALS research · 2024-05-03Clinical Trial Update: Pacritinib w/ Talazoparib in Pts w/ Myeloproliferative Neoplasms Unresponsive to JAK2 Inhibition [Phase 1]
A Phase 1 clinical trial at Fox Chase Cancer Center tests the combination of pacritinib and talazoparib in myeloproliferative neoplasms unre…
-
CLINICAL_TRIALS research · 2017-07-26Clinical Trial Update: Hydroxyurea Versus Aspirin and Hydroxyurea in Essential Thrombocythemia [Phase 3]
This clinical trial update describes a Phase 3 study comparing hydroxyurea alone versus hydroxyurea with aspirin in essential thrombocythemi…
-
CLINICAL_TRIALS research · 2017-07-02Clinical Trial Update: Molecular Changes and Biomarkers in Chronic Myeloproliferative Disorders
A completed NIH-backed clinical trial examining molecular changes and biomarkers in chronic myeloproliferative disorders including polycythe…
-
CLINICAL_TRIALS research · 2015-11-17Clinical Trial Update: Safety and Pregnancy Outcomes in Thrombocythemia Patients Exposed to XAGRID® (Anagrelide Hydrochloride) Compared to Other Treatments
Clinical trial update reporting safety and pregnancy outcomes in thrombocythemia patients exposed to XAGRID compared with other treatments.
-
CLINICAL_TRIALS research · 2014-11-26Clinical Trial Update: CEP-701 (Lestaurtinib) in Myelofibrosis [Phase 1, Phase 2]
Clinical trial update on CEP-701 (lestaurtinib) in myelofibrosis, with additional conditions essential thrombocythemia and polycythemia vera…
-
CLINICAL_TRIALS research · 2013-03-21Clinical Trial Update: Myeloproliferative Neoplasms and Bone Structure
This is a clinical trial update on myeloproliferative neoplasms and bone structure. The current status of the study is unknown.
-
CLINICAL_TRIALS research · 2011-12-12Clinical Trial Update: A Study of the Efficacy of MK-0683 in Patients With Polycythaemia Vera and Essential Thrombocythaemia [Phase 2]
This is a Phase 2 clinical trial evaluating MK-0683 for efficacy in Polycythemia Vera and Essential Thrombocythemia; current status is unkno…